MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,308,844 | -63.8% | 1,030,586 | -6.2% | 0.00% | -100.0% |
| Q2 2023 | $3,616,042 | -0.5% | 1,099,101 | +24.2% | 0.00% | 0.0% |
| Q1 2023 | $3,635,843 | -31.4% | 884,633 | -2.2% | 0.00% | 0.0% |
| Q4 2022 | $5,299,644 | -10.1% | 904,376 | +3.7% | 0.00% | 0.0% |
| Q3 2022 | $5,896,000 | +49.0% | 872,220 | +1.8% | 0.00% | 0.0% |
| Q2 2022 | $3,957,000 | +36.9% | 856,486 | +18.3% | 0.00% | 0.0% |
| Q1 2022 | $2,890,000 | -37.9% | 724,255 | -3.2% | 0.00% | 0.0% |
| Q4 2021 | $4,651,000 | -29.2% | 747,876 | +7.3% | 0.00% | 0.0% |
| Q3 2021 | $6,573,000 | -29.1% | 697,013 | +2.1% | 0.00% | -50.0% |
| Q2 2021 | $9,271,000 | -3.4% | 682,687 | +15.1% | 0.00% | 0.0% |
| Q1 2021 | $9,599,000 | -42.9% | 593,220 | -6.1% | 0.00% | -33.3% |
| Q4 2020 | $16,806,000 | +42.0% | 631,538 | -0.6% | 0.00% | 0.0% |
| Q3 2020 | $11,833,000 | +123.9% | 635,522 | +181.4% | 0.00% | +200.0% |
| Q2 2020 | $5,286,000 | +124.8% | 225,855 | -44.0% | 0.00% | 0.0% |
| Q1 2020 | $2,351,000 | +5.6% | 403,338 | +3.8% | 0.00% | – |
| Q4 2019 | $2,227,000 | +262.7% | 388,616 | +0.1% | 0.00% | – |
| Q3 2019 | $614,000 | -25.8% | 388,384 | +90.2% | 0.00% | – |
| Q2 2019 | $827,000 | -12.7% | 204,194 | +13.4% | 0.00% | – |
| Q1 2019 | $947,000 | +67.0% | 180,068 | +29.4% | 0.00% | – |
| Q4 2018 | $567,000 | -61.2% | 139,114 | -4.7% | 0.00% | – |
| Q3 2018 | $1,460,000 | -35.7% | 146,030 | +14.8% | 0.00% | -100.0% |
| Q2 2018 | $2,271,000 | +29.0% | 127,162 | +13.9% | 0.00% | – |
| Q1 2018 | $1,761,000 | +102.4% | 111,669 | +111.0% | 0.00% | – |
| Q4 2017 | $870,000 | +31.6% | 52,926 | +38.5% | 0.00% | – |
| Q3 2017 | $661,000 | – | 38,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |